Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease

A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease

NCT00446433 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

NCT02435992 ·Status: COMPLETED ·Phase: PHASE3

Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease

NCT03854305 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

NCT05470985 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease

NCT01203631 ·Status: COMPLETED ·Phase: PHASE2

Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

NCT01218360 ·Status: COMPLETED

Treatment of Moderate to Severe Refractory Crohn's Disease

NCT06721962 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

NCT03440385 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's Disease

NCT03870334 ·Status: TERMINATED ·Phase: PHASE2

Extension Study of MT-1303 in Subjects With Crohn's Disease

NCT02389790 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease

NCT01951326 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating rhIL-11 in Active Crohn's Disease

NCT00040521 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Study of FFP104 in Subjects With Crohn's Disease

NCT02465944 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease

NCT04102111 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

NCT02378688 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease

NCT04151225 ·Status: WITHDRAWN ·Phase: PHASE2

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

NCT03677648 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

NCT03105102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

CP-461 for the Treatment of Crohn's Disease

NCT00042055 ·Status: COMPLETED ·Phase: PHASE2

Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

NCT03440372 ·Status: TERMINATED ·Phase: PHASE3

Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease

NCT00280956 ·Status: COMPLETED ·Phase: PHASE4

MSC Intratissular Injection in Crohn Disease Patients

NCT03901235 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease

NCT00615199 ·Status: COMPLETED ·Phase: PHASE2

Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol

NCT01190410 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease

NCT05057273 ·Status: WITHDRAWN ·Phase: PHASE2